BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20727049)

  • 1. Editorial comment to Anterior perirectal fat tissue thickness closely associated with obesity strongly predicts recurrence after high-intensity focused ultrasound for prostate cancer.
    Hekal IA
    Int J Urol; 2010 Sep; 17(9):782-3. PubMed ID: 20727049
    [No Abstract]   [Full Text] [Related]  

  • 2. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.
    Sumitomo M; Asakuma J; Yoshii H; Sato A; Horiguchi A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Sep; 17(9):776-82. PubMed ID: 20569272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity focused ultrasound: a potential salvage treatment for recurrent prostate cancer following radiotherapy.
    Acher PL; Thwaini A; Shergill IS; Barua JM
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):969-70. PubMed ID: 16831068
    [No Abstract]   [Full Text] [Related]  

  • 4. [High intensity focused pulsed ultrasound (HIFU) for local ablation of prostate carcinoma].
    Thüroff S; Chaussy C
    Urologe A; 2007 Sep; 46(9):1092. PubMed ID: 17593339
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment to Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
    Uchida T
    Int J Urol; 2010 Nov; 17(11):930. PubMed ID: 20969641
    [No Abstract]   [Full Text] [Related]  

  • 6. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience.
    Mearini L; D'Urso L; Collura D; Zucchi A; Costantini E; Formiconi A; Bini V; Muto G; Porena M
    J Urol; 2009 Jan; 181(1):105-11; discussion 111-2. PubMed ID: 19081465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment to Radical prostatectomy in obese patients: improved surgical outcomes in recent years.
    van Roermund JG
    Int J Urol; 2010 Aug; 17(8):732-3. PubMed ID: 20649830
    [No Abstract]   [Full Text] [Related]  

  • 11. High-intensity focused ultrasound for localized prostate cancer: ready for prime time?
    Bastian PJ
    Eur Urol; 2010 Oct; 58(4):514-5; discussion 515-6. PubMed ID: 20728267
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity and prostate cancer: a growing problem.
    Freedland SJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6763-6. PubMed ID: 16203761
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer.
    Eastham JA
    Eur Urol; 2008 Jun; 53(6):1202-3. PubMed ID: 17997016
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer.
    Ficarra V; Novara G
    Eur Urol; 2008 Jun; 53(6):1201-2. PubMed ID: 17997014
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment.
    Moul JW
    Urology; 2010 Feb; 75(2):445-6; author reply 446. PubMed ID: 20152507
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Slawin KM
    Urology; 2010 Feb; 75(2):444-5; author reply 445. PubMed ID: 20152505
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.